Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Several vaccine candidates to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (COVID-19) have entered or will soon enter large-scale, phase 3, placebo-controlled randomized clinical trials. To facilitate harmonized evaluation and com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intern Med
Main Authors: Mehrotra, Devan V., Janes, Holly E., Fleming, Thomas R., Annunziato, Paula W., Neuzil, Kathleen M., Carpp, Lindsay N., Benkeser, David, Brown, Elizabeth R., Carone, Marco, Cho, Iksung, Donnell, Deborah, Fay, Michael P., Fong, Youyi, Han, Shu, Hirsch, Ian, Huang, Ying, Huang, Yunda, Hyrien, Ollivier, Juraska, Michal, Luedtke, Alex, Nason, Martha, Vandebosch, An, Zhou, Honghong, Cohen, Myron S., Corey, Lawrence, Hartzel, Jonathan, Follmann, Dean, Gilbert, Peter B.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Physicians 2020
Assuntos:
Research and Reporting Methods
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596738/
https://ncbi.nlm.nih.gov/pubmed/33090877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-6169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados